Brief: Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements

CervoMed

04/05/2022 14:25

May 4 (Reuters) - Diffusion Pharmaceuticals Inc  DFFN.O :
    * DIFFUSION PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ
LISTING
REQUIREMENTS

Source text for Eikon:  ID:nGNX4d3yl2 
Further company coverage:  DFFN.O 

 ((reuters.briefs@thomsonreuters.com;))